Pharma

By Jonah Comstock March 1, 2018
Pear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia. It’s the first time a pharma company has made a development deal with a digital therapeutic, according to Pear. “We have been in discussions for many months now with the [Novartis Institutes for BioMedical Research] group at...
By Laura Lovett February 5, 2018
Its not uncommon to see customers paying for coffee or boarding a flight using a QR code from their smartphone, but some researchers are now looking to create an edible medication QR code. Researchers at the University of Copenhagen recently published a study in the International Journal of Pharmaceutics which looks at creating QR-encoded smart oral medication made by inkjet printing.  "This...
Chelsea and Westminster Hospital
By Leontina Postelnicu January 25, 2018
During the past year, Chelsea and Westminster Hospital NHS Foundation Trust and its charity, CW+, have been showing how digital health innovation can truly take off in a large healthcare organisation if the right type of support is at hand. In 2016, the trust and CW+ secured eight digital health collaborations, working with more than 45 frontline clinicians across two hospital sites, with six of...
By Jonah Comstock January 18, 2018
San Francisco-based MyHealthTeams has added its 28th disease-specific social network, and is working with Belgian pharmaceutical company UCB on an educational inititative related to the platform. MySpondylitisTeam, the newest network, is aimed at patients with spondyloarthritis, a kind of arthritis which, unlike rheumatoid arthritis, tends to first present itself when patients are in their 20s...
Doctor at computer.
By Leontina Postelnicu January 10, 2018
As strategists are accelerating transformation in the face of increasing demand, the pace of technological advancements and shifts in the public’s perception of digital health concepts, when speaking to experts in the field, it is clear that, in 2018, disruption in the field will finally start to come to ‘fruition’. Senior analysts from American firm Forrester Research argue that it is ‘already...
By Jonah Comstock December 27, 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health,...
By Laura Lovett December 20, 2017
Correction: A previous version of this article misstated that ACE was the name of the mobile app. ACE is the name of PharMedQuest's customer relationship management platform and not the mobile app.  Healthcare management company PharMedQuest announced last week that it has made a strategic investment in helparound, an Israeli company which makes an app that supports and connects patients with...
By Dave Muoio December 1, 2017
Editor's note: Since publication, some of this story's quotes have been edited for clarity. With billions of dollars and countless hours of human effort spent each year validating new drugs, devices, and medical interventions, it’s little surprise that the healthcare industry is turning to technology to streamline the process. From participant recruitment to data collection to adherence, clinical...
Whitehall exterior of building
By Leontina Postelnicu November 22, 2017
The UK government will open a Centre for Data Ethics and Innovation to ensure ethical standards are at the forefront of AI and data-driven technology development. The new advisory body will work with regulators, the industry and the government to pave the way for sensible AI adoption. In addition, more than £75m will be invested to deliver recommendations from Professor Dame Wendy Hall and Jérôme...
By Jonah Comstock November 17, 2017
Correction: An earlier version of this article was unclear about differences between Abilify MyCite and the Proteus Digital Medicine Platform.  Earlier this week, Proteus Digital Health and Otsuka Pharmaceuticals announced that Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia, had received FDA approval for mental health conditions including schizophrenia and...